The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 334:736-737 March 14, 1996 Number 11
NextNext

Survival of Patients with Turcot's Syndrome and Glioblastoma

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Hamilton, S. R.
-PubMed Citation
To the Editor: Using molecular evidence, Hamilton et al. (March 30 issue)1 defined two germ-line defects associated with Turcot's syndrome, one of which is usually found in hereditary nonpolyposis colorectal cancer, and the other of which is usually found in familial adenomatous polyposis. The former defect is characterized by mutations in mismatch-repair genes, which lead to widespread microsatellite instability. Exceptional survival rates of more than three years have been reported in three patients with glioblastoma linked to the form of Turcot's syndrome characterized by colorectal cancer,1 whereas the expected median survival rate is about eight months.2 Thus, the question arises . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.